The RxPress
RxPress Issues
November-December 2010 edition
- Preexposure Prophylaxis Initiative (iPrEx) Trial
- N-Acetylcysteine (NAC) and Contrast-Induced Nephropathy: ACT Trial Results
- AHA Guidelines for Cardiopulmonary Resuscitation: Update
- P&T Committee Formulary Action
September-October 2010 edition
- New Practice Guidelines for Chronic Pain Management
- Safety Concerns with Propoxyphene & UPDATE
- Opioid Risk Evaluation and Mitigation Strategy
- UIMC Patient-Controlled Analgesia (PCA) Guidelines in Adults
- P&T Committee Formulary Action
- Rosiglitazone: An Update
- Polypill for the Prevention of Heart Disease
- Children with Hyperlipidemia: Screening and Treatment Recommendations
- P & T Committee Formulary Action
- Sound-alike -- Look-alike drugs and the risk for error
- Clostridium difficile clinical practice guidelines: summary of treatment
- Safety of gadolinium-based contrast media
- P&T Committee Formulary Action
- Food and Drug Administration 2010 Safety News
- Medication Errors and Modified Release Dosage Forms
- Long Term Adverse Effects of Proton Pump Inhibitors
- P&T Committee Formulary Action
- Practice Guideline Updates - ADA, Immunization, and Perioperative Beta-Blockade
- Literature Update - ACCORD and JUPITER
- P&T Committee Formulary Actions
November-December 2009 edition
- Infections in the ICU
- Use of Contraindicated Medications in Dialysis Patients Undergoing PCI
- Medication-Associated Falls in the Elderly
- P&T Committee Formulary Action
September-October 2009 edition
- H1N1 Influenza
- UIMC Executive Summary of the Management of Novel Influenza A (H1N1) Virus
- Emergency Use of Peramivir Approved
- P&T Committee Formulary Action
- Recent Food and Drug Administration Medication Safety Actions
- Varenicline, Bupropion, Propoxyphene, TNF blockers
- Etravirine, Orlistat, Insulin glargine
- P&T Formulary Update
- Acetaminophen: recommendations from the FDA Advisory Committee
- Recombinant human erythropoiesis-stimulating agents and mortality in cancer patients
- Hospital-acquired pneumonia: risks with acid suppression therapies
- Updated guidelines for nutrition support in the adult critically ill patient: SCCM and A.S.P.E.N.
- P&T Committee Formulary Action
- Antiplatelet therapy and GI Risk
- Update on HIV Opportunistic Infections
- Aspirin for Primary Prevention
- Update on PPI and Clopidogrel Interaction
- P&T Committee Formulary Action
- Intensive Glycemic Control and Cardiovascular Events: An Update
- The Utilization of Pharmacogenomics in Clinical Practice
- Dalteparin Use Guideline
- P&T Committee Formulary Action
^ Top of Page ^